OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell methods in myeloproliferative neoplasms: old questions, new technologies
Jennifer O’Sullivan, Adam J. Mead, Bethan Psaila
Blood (2022) Vol. 141, Iss. 4, pp. 380-390
Open Access | Times Cited: 14

Showing 14 citing articles:

Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
Laura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1520-1531
Open Access | Times Cited: 12

A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, M. Colombo, Guanlin Wang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 768
Open Access | Times Cited: 4

Potential application of the bulk RNA sequencing in routine MPN clinics
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access

Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts
Lara Tavernari, Sebastiano Rontauroli, Ruggiero Norfo, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 1939-1950
Open Access | Times Cited: 3

Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective
Sebastiano Rontauroli, Chiara Carretta, Sandra Parenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15256-15256
Open Access | Times Cited: 8

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms
Mirjana Cvetković, Isidora Arsenović, Mihailo Smiljanić, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1

Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Molecular profiling in MPN: who should have it and why?
Ashlyn Chee, Adam J. Mead
Hematology (2024) Vol. 2024, Iss. 1, pp. 524-534
Closed Access | Times Cited: 1

A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis
Rong Li, M. Colombo, Guanlin Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Advances in next-generation sequencing and emerging technologies for haematologic malignancies
Regina Kwon, Cecilia C.S. Yeung
Haematologica (2023) Vol. 109, Iss. 2, pp. 379-387
Open Access | Times Cited: 3

Potential application of bulk RNA sequence in MPNs clinic routine
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
Research Square (Research Square) (2024)
Open Access

The impact of next-generation sequencing for diagnosis and disease understanding of myeloid malignancies
Erica Vormittag‐Nocito, Madina Sukhanova, Lucy A. Godley
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 7, pp. 591-600
Closed Access

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
Judith M. Bliss, Spencer Krichevsky, Joseph M. Scandura, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access

Page 1

Scroll to top